High-expressed SLC16A1 has also been found to be associated with lymph node metastasis and distant metastasis of bladder cancer, thereby showing a negative impact on the overall survival of patients. This evidence concerns the gene SLC16A1 and metastatic malignant neoplasm in the lymph nodes.